PRESS RELEASE published on 03/24/2023 at 11:11, 1 year 7 months ago Form 8.3 - Maitland Institutional Services Limited: Re finnCap plc
PRESS RELEASE published on 03/23/2023 at 13:42, 1 year 7 months ago Form 8.3 - Maitland Institutional Services Limited: Re Curtis Banks Group PLC
PRESS RELEASE published on 03/16/2023 at 16:33, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Re Reabold Resources Plc
PRESS RELEASE published on 03/14/2023 at 13:25, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Re Curtis Banks Group PLC
PRESS RELEASE published on 03/09/2023 at 13:21, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Re Curtis Banks Group plc
PRESS RELEASE published on 03/02/2023 at 15:41, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Re Curtis Banks Group plc
PRESS RELEASE published on 03/02/2023 at 13:35, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Re Purple Bricks Group plc
PRESS RELEASE published on 03/01/2023 at 11:46, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Curtis Banks Group Plc
PRESS RELEASE published on 02/27/2023 at 11:21, 1 year 8 months ago Form 8.3 - Maitland Institutional Services Limited: Re Purple Bricks Group PLC
PRESS RELEASE published on 02/20/2023 at 16:38, 1 year 9 months ago Form 8.3 - Maitland Institutional Services Limited: Re Purple Bricks Group plc - Replacement Disclosure
Published on 11/21/2024 at 13:30, 15 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 15 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 45 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 45 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 45 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 9 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 29 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
